Cancer Research AACR Membership  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 5329-5338, October 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, I. G.
Right arrow Articles by Trowsdale, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, I. G.
Right arrow Articles by Trowsdale, J.

Folate-binding Protein Is a Marker for Ovarian Cancer

Ian G. Campbell, Tania A. Jones, William D. Foulkes and John Trowsdale1

Imperial Cancer Research Fund, P.O. Box 123, Lincoln's Inn Fields, London WC2A 3PX, England

We describe the isolation of a complementary DNA (cDNA) sequence encoding the ovarian cancer-associated antigen recognized by monoclonal antibody MOv18 and its identification as a high-affinity folate-binding protein (FBP). Functional cDNA clones were isolated using mRNA from the ovarian carcinoma cell line SKOV3 and colon carcinoma cell line HT29, by transient expression in WOP cells and selection of expressing cells by adhesion to antibody-coated magnetic beads. The cDNAs differed in the lengths of 5'- and 3'-noncoding regions, but they encoded identical peptides. A database search clearly showed them to be adult high-affinity FBPs with amino acid sequences identical with those isolated from normal placenta and several carcinoma cell lines. Reactivity of cell lines with MOv18 was quantitatively consistent with the expression of FBP mRNA. Southern hybridizations show evidence of a family of related genes and/or pseudogenes and were mapped to chromosome 11q13.3–14.1 by fluorescent in situ hybridization using cosmid clones containing part of this region. Also identified were two PstI polymorphisms of four and three alleles, respectively, and a two-allele MspI polymorphism. The folate-binding protein locus was not amplified in any of the 16 carcinoma cell lines tested and in only 1 of 10 serous adenocarcinomas, indicating that overexpression of FBP in ovarian cancer cannot, in general, be due to gene amplification.

1 To whom requests for reprints should be addressed.

Received 3/ 8/91. Accepted 7/25/91.




This article has been cited by other articles:


Home page
aacredbookHome page
A. L Jackman
Exploiting Folate Pathways and Transporters for the Management and Treatment of Cancer
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 101 - 108.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Iwakiri, M. Sonobe, S. Nagai, T. Hirata, H. Wada, and R. Miyahara
Expression Status of Folate Receptor {alpha} Is Significantly Correlated with Prognosis in Non-Small-Cell Lung Cancers
Ann. Surg. Oncol., March 1, 2008; 15(3): 889 - 899.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. N. Karagiannis, M. G. Bracher, J. Hunt, N. McCloskey, R. L. Beavil, A. J. Beavil, D. J. Fear, R. G. Thompson, N. East, F. Burke, et al.
IgE-Antibody-Dependent Immunotherapy of Solid Tumors: Cytotoxic and Phagocytic Mechanisms of Eradication of Ovarian Cancer Cells
J. Immunol., September 1, 2007; 179(5): 2832 - 2843.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Yang, E. A. Kolb, J. Qin, A. Chou, R. Sowers, B. Hoang, J. H. Healey, A. G. Huvos, P. A. Meyers, and R. Gorlick
The Folate Receptor {alpha} Is Frequently Overexpressed in Osteosarcoma Samples and Plays a Role in the Uptake of the Physiologic Substrate 5-Methyltetrahydrofolate
Clin. Cancer Res., May 1, 2007; 13(9): 2557 - 2567.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. L. Knutson, C. J. Krco, C. L. Erskine, K. Goodman, L. E. Kelemen, P. J. Wettstein, P. S. Low, L. C. Hartmann, and K. R. Kalli
T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer
J. Clin. Oncol., September 10, 2006; 24(26): 4254 - 4261.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. E. Kelemen, T. A. Sellers, G. L. Keeney, and W. L. Lingle
Multivitamin and Alcohol Intake and Folate Receptor {alpha} Expression in Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2168 - 2172.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. F. Kukowska-Latallo, K. A. Candido, Z. Cao, S. S. Nigavekar, I. J. Majoros, T. P. Thomas, L. P. Balogh, M. K. Khan, and J. R. Baker Jr.
Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer
Cancer Res., June 15, 2005; 65(12): 5317 - 5324.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. S. Jhaveri, A. S. Rait, K.-N. Chung, J. B. Trepel, and E. H. Chang
Antisense oligonucleotides targeted to the human {alpha} folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
Mol. Cancer Ther., December 1, 2004; 3(12): 1505 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Chattopadhyay, Y. Wang, R. Zhao, and I. D. Goldman
Lack of Impact of the Loss of Constitutive Folate Receptor {alpha} Expression, Achieved by RNA Interference, on the Activity of the New Generation Antifolate Pemetrexed in HeLa Cells
Clin. Cancer Res., December 1, 2004; 10(23): 7986 - 7993.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. S. Theti and A. L. Jackman
The Role of {alpha}-Folate Receptor-Mediated Transport in the Antitumor Activity of Antifolate Drugs
Clin. Cancer Res., February 1, 2004; 10(3): 1080 - 1089.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Andersson, J. Elgqvist, G. Horvath, R. Hultborn, L. Jacobsson, H. Jensen, B. Karlsson, S. Lindegren, and S. Palm
Astatine-211-labeled Antibodies for Treatment of Disseminated Ovarian Cancer: An Overview of Results in an Ovarian Tumor Model
Clin. Cancer Res., September 1, 2003; 9(10): 3914S - 3921.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. S. Theti, V. Bavetsias, L. A. Skelton, J. Titley, D. Gibbs, G. Jansen, and A. L. Jackman
Selective Delivery of CB300638, a Cyclopenta[g]quinazoline-based Thymidylate Synthase Inhibitor into Human Tumor Cell Lines Overexpressing the {alpha}-Isoform of the Folate Receptor
Cancer Res., July 1, 2003; 63(13): 3612 - 3618.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. M. M. Kelley, B. G. Rowan, and M. Ratnam
Modulation of the Folate Receptor {alpha} Gene by the Estrogen Receptor: Mechanism and Implications in Tumor Targeting
Cancer Res., June 1, 2003; 63(11): 2820 - 2828.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Hao, H. Qi, and M. Ratnam
Modulation of the folate receptor type {beta} gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites
Blood, June 1, 2003; 101(11): 4551 - 4560.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Zheng, K. Kelley, H. Elnakat, W. Yan, T. Dorn, and M. Ratnam
mRNA Instability in the Nucleus Due to a Novel Open Reading Frame Element Is a Major Determinant of the Narrow Tissue Specificity of Folate Receptor {alpha}
Mol. Cell. Biol., March 15, 2003; 23(6): 2202 - 2212.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Boucherot, R. Schreiber, H. Pavenstadt, and K. Kunzelmann
Cloning and expression of the mouse glomerular podoplanin homologue gp38P
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 978 - 984.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. D. Hough, K. R. Cho, A. B. Zonderman, D. R. Schwartz, and P. J. Morin
Coordinately Up-Regulated Genes in Ovarian Cancer
Cancer Res., May 1, 2001; 61(10): 3869 - 3876.
[Abstract] [Full Text]


Home page
JNMHome page
G. W. Visser, R. P. Klok, J. W. K. Gebbinck, T. ter Linden, G. A. van Dongen, and C. F. Molthoff
Optimal Quality 131I-Monoclonal Antibodies on High-Dose Labeling in a Large Reaction Volume and Temporarily Coating the Antibody with IODO-GEN
J. Nucl. Med., March 1, 2001; 42(3): 509 - 519.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. M. Trippett, S. Garcia, K. Manova, R. Mody, L. Cohen-Gould, W. Flintoff, and J. R. Bertino
Localization of a Human Reduced Folate Carrier Protein in the Mitochondrial as Well as the Cell Membrane of Leukemia Cells
Cancer Res., March 1, 2001; 61(5): 1941 - 1947.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. da Costa, S. P. Rothenberg, E. Sadasivan, A. Regec, and L. Qian
Folate deficiency reduces the GPI-anchored folate-binding protein in rat renal tubules
Am J Physiol Cell Physiol, April 1, 2000; 278(4): C812 - C821.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Z. Zhao, K. A. Koeplinger, T. Peterson, R. A. Conradi, P. S. Burton, A. Suarato, R. L. Heinrikson, and A. G. Tomasselli
Mechanism, Structure-Activity Studies, and Potential Applications of Glutathione S-Transferase-Catalyzed Cleavage of Sulfonamides
Drug Metab. Dispos., September 1, 1999; 27(9): 992 - 998.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. M. Maziarz, H. L. Monaco, F. Shen, and M. Ratnam
Complete Mapping of Divergent Amino Acids Responsible for Differential Ligand Binding of Folate Receptors alpha  and beta
J. Biol. Chem., April 16, 1999; 274(16): 11086 - 11091.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
R. H. Finnell, K. A. Greer, R. C. Barber, J. A. Piedrahita, G. M. Shaw, and E. J. Lammer
Neural Tube and Craniofacial Defects With Special Emphasis On Folate Pathway Genes
Critical Reviews in Oral Biology & Medicine, January 1, 1998; 9(1): 38 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-L. Sun and X. L. Sun
Evidence That a Specific Interaction Between an 18-Base cis-Element in the 5'-Untranslated Region of Human Folate Receptor-alpha mRNA and a 46-kDa Cytosolic trans-Factor is Critical for Translation
J. Biol. Chem., October 11, 1996; 271(41): 25539 - 25547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Murray, F. M.R. Williams, and W. F. Flintoff
Structural Organization of the Reduced Folate Carrier Gene in Chinese Hamster Ovary Cells
J. Biol. Chem., August 9, 1996; 271(32): 19174 - 19179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Lee and L. Huang
Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer
J. Biol. Chem., April 5, 1996; 271(14): 8481 - 8487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Spinella, K. E. Brigle, E. E. Sierra, and I. D. Goldman
Distinguishing between Folate Receptor-alpha-mediated Transport and Reduced Folate Carrier-mediated Transport in L1210 Leukemia Cells
J. Biol. Chem., April 7, 1995; 270(14): 7842 - 7849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. M. R. Williams and W. F. Flintoff
Isolation of a Human cDNA That Complements a Mutant Hamster Cell Defective in Methotrexate Uptake
J. Biol. Chem., February 17, 1995; 270(7): 2987 - 2992.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.